MarketsNotableConfirmedDeveloping
9.3
US asset managers increase stakes in WuXi AppTec amid weight-loss drug demand
South China Morning PostLO·US · CN·3 days ago
HealthSingle-sourceLow
2.1
Sarepta Therapeutics appoints Michael Severino as new CEO
Sarepta Therapeutics has appointed former Tessera Therapeutics CEO Michael Severino to lead the company. This leadership transition follows a period of operational challenges for the firm, though the strategic impact of the appointment remains to be seen.
Score Breakdown
Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3
Related signals
8 foundHealthNotableSingle-source
5.2
Argenx to acquire Forte Biosciences for $2.2 billion to expand immunology pipeline
Le SoirLO·BE · US·about 13 hours ago
MarketsNotableEmergingDeveloping
4.6
AstraZeneca portfolio setback fuels speculation of Wallenberg-led M&A
Dagens IndustriLO·SE · GB·about 9 hours ago
HealthSingle-sourceDeveloping
2.1
Oak Hill Bio secures funding to develop Angelman syndrome therapy
STAT NewsLO·US·about 7 hours ago
GeopoliticsNotableConfirmed
10.0
UK Prime Minister Burnham signals willingness to challenge US leadership on national interest grounds
N1 SerbiaLO·GB · US·about 22 hours ago
DefenseHighConfirmedAccelerating
10.0
Leadership transition in Ukrainian Armed Forces following Syrskyi departure
Kyiv Independent·UA·3 days ago
PoliticsHighConfirmedAccelerating
10.0
Bangladesh President Mohammed Shahabuddin resigns citing health reasons
Al Jazeera·BD·3 days ago
PoliticsHighConfirmedAccelerating
10.0
Reports of communication blackout surrounding Mojtaba Khamenei
Anadolu Agency EN·IR·1 day ago